CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
28 déc. 2022 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Dec. 28, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors
20 déc. 2022 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative...
CVRx to Present at the Piper Sandler 34th Annual Healthcare Conference
16 nov. 2022 08h00 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 16, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Launches new Barostim NEO2™ Implantable Pulse Generator
03 nov. 2022 10h31 HE
|
CVRx, Inc.
The new Barostim NEO2 Implantable Pulse Generator (IPG) launches in the U.S., improving the patient experience while on therapy and simplifying the implant procedure for physicians MINNEAPOLIS, Nov. ...
CVRx to Attend Upcoming Investor Conferences
03 nov. 2022 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Reports Third Quarter 2022 Financial and Operating Results
01 nov. 2022 16h15 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call on November 1st, 2022
18 oct. 2022 16h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Oct. 18, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx to Present at the Canaccord Genuity 42nd Annual Growth Conference
29 juil. 2022 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, July 29, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Reports Second Quarter 2022 Financial and Operating Results
28 juil. 2022 16h10 HE
|
CVRx, Inc.
MINNEAPOLIS, July 28, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call
14 juil. 2022 16h30 HE
|
CVRx, Inc.
MINNEAPOLIS, July 14, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...